Johnson & Johnson (NYSE: JNJ) managed to marginally beat earnings expectations this Tuesday morning. This is the first of the consumer products and medical products companies to report, so this one could have a heavier impact depending on what is said.
The company beat earnings at $1.13 EPS and sales rose almost 4% to $16.25 billion; estimates were $1.09 EPS and $16.28 billion in sales from Thomson Reuters. The company noted that operational sales were up 4.0% and its negative currency impact was only 0.1% as domestic sales fell by 3.4% and international sales rose by just over 10% in the quarter.
For the Fiscal Year 2012, J&J sees earnings of $5.05 to $5.15 EPS and that is a bit shy of the $5.21 consensus target based upon operational growth of down slightly to as high as 5.5% and based upon a negative currency impact of around 2.5%.
J&J’s guidance is weighing on the stock. Shares are indicated down 0.75% at $64.50 against a 52-week trading range of $57.50 to $68.05 and versus a Thomson Reuters consensus price target of $73.00.
The report has remained better than many may have guessed considering all of the product problems before. Unfortunately, there is little driving force here that stands out as great opportunity.
JON C. OGG
Travel Cards Are Getting Too Good To Ignore (sponsored)
Credit card companies are pulling out all the stops, with the issuers are offering insane travel rewards and perks.
We’re talking huge sign-up bonuses, points on every purchase, and benefits like lounge access, travel credits, and free hotel nights. For travelers, these rewards can add up to thousands of dollars in flights, upgrades, and luxury experiences every year.
It’s like getting paid to travel — and it’s available to qualified borrowers who know where to look.
We’ve rounded up some of the best travel credit cards on the market. Click here to see the list. Don’t miss these offers — they won’t be this good forever.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.